517
Articles
12.1K
Citations
2.4
avg. Impact Factor
48
h-index

Most Cited Articles of Department of Medical Oncology in 2022

TitleJournalYearCitations
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.New England Journal of Medicine202230
Adjuvant S-1 versus observation in curatively resected biliary tract cancer: A phase III trial (JCOG1202: ASCOT).Journal of Clinical Oncology20223
Prevalence estimates of Helicobacter species infection in pancreatic and biliary tract cancers.Helicobacter20222
A phase II study of nivolumab in combination with modified FOLFIRINOX for metastatic pancreatic cancer.Journal of Clinical Oncology20222
Right ventricular overloading is attenuated in monocrotaline-induced pulmonary hypertension model rats with a disrupted Gpr143 gene, the gene that encodes the 3,4-l-dihydroxyphenyalanine (l-DOPA) receptor.Journal of Pharmacological Sciences20222
Assessment of the use of computed tomography colonography in early detection of peritoneal metastasis in patients with gastric cancer: A prospective cohort study.PLoS ONE20221
Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study).20221
Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib TreatmentCurrent Oncology20221
Comparative Outcomes of First-Line Chemotherapy for Metastatic Pancreatic Cancer Among the Regimens Used in Japan: A Systematic Review and Network Meta-analysis.JAMA Network Open20220
The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113.Scientific Reports20220
Randomized multicenter phase II/III study of gemcitabine plus nab-paclitaxel or modified FOLFIRINOX or S-IROX in patients with metastatic or recurrent pancreatic cancer (JCOG1611, GENERATE).Journal of Clinical Oncology20220
Identification and quantitative structure-activity relationship assessment of trace chemical impurities contained in the therapeutic formulation of [Cu]Cu-ATSM.Nuclear Medicine and Biology20220
Impact of the KIT/PDGFRA genotype on prognosis in imatinib-naïve Japanese patients with gastrointestinal stromal tumor.Annals of Gastroenterological Surgery20220
Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma.Scientific Reports20220
Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA Substudy.JCO Precision Oncology20220
Authors' reply to the Letter to the Editor: Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancer.Cancer Science20220
Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients.PLoS ONE20220
Comparative study between sorafenib and lenvatinib as the first-line therapy in the sequential treatment of unresectable hepatocellular carcinoma in a real-world setting.JGH Open20220
Sarcopenia: Prognostic Value for Unresectable Pancreatic Ductal Adenocarcinoma Patients Treated With Gemcitabine Plus Nab-Paclitaxel.Pancreas20220
A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma.BMC Cancer20220
Feasibility of adjuvant S-1 chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202.Journal of Clinical Oncology2022
Nal-IRI+5-FU/LV vs 5-FU/LV in metastatic pancreatic cancer: Additional safety report of randomized Japanese phase 2 trial.Journal of Clinical Oncology2022
The influence of major hepatectomy on gemcitabine-based chemotherapy for advanced biliary tract cancer: An exploratory subset analysis of JCOG1113.Journal of Clinical Oncology2022
A prospective observational study of lenvatinib as an initial treatment for patients with intermediate-stage hepatocellular carcinoma.Journal of Clinical Oncology2022
Successful treatment with brentuximab vedotine for a patient with very late relapse of limited stage classic Hodgkin lymphoma.International Cancer Conference Journal2022